Loading clinical trials...
Loading clinical trials...
A Phase 1, Double-Blind, Parallel, Placebo-Controlled, Randomized Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Acceptability of PC-1005 Microbicide Gel Formulation in HIV-seronegative Women
Conditions
Interventions
PC-1005
HEC gel
Locations
1
United States
University of Alabama at Birmingham
Birmingham, Alabama, United States
Start Date
May 1, 2014
Primary Completion Date
April 1, 2015
Completion Date
June 1, 2015
Last Updated
August 15, 2017
NCT01875588
NCT04929028
NCT07071623
NCT03087253
NCT07199335
NCT05419024
Lead Sponsor
Population Council
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions